-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Q48Hilz4fwbvt7NMUc3Bm8FBWBvoQxWBH4L9v1XIQlpfugEYzL9Sz4YUR3QKaAWe rcY367C34qzlxwNpouPE5g== 0001193125-10-234618.txt : 20101022 0001193125-10-234618.hdr.sgml : 20101022 20101022161154 ACCESSION NUMBER: 0001193125-10-234618 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20101022 DATE AS OF CHANGE: 20101022 EFFECTIVENESS DATE: 20101022 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ZYMOGENETICS INC CENTRAL INDEX KEY: 0001129425 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911144498 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-33489 FILM NUMBER: 101137464 BUSINESS ADDRESS: STREET 1: 1201 EASTLAKE AVENUE E CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 206-442-6600 MAIL ADDRESS: STREET 1: 1201 EASTLAKE AVENUE E CITY: SEATTLE STATE: WA ZIP: 98102 15-12G 1 d1512g.htm FORM 15 Form 15

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number: 000-33489

ZYMOGENETICS, INC.

(Exact name of registrant as specified in its charter)

1201 Eastlake Avenue East

Seattle, Washington 98102-3702

(206) 442-6600

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock, no par value

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)    x
Rule 12g-4(a)(2)    ¨
Rule 12h-3(b)(1)(i)    x
Rule 12h-3(b)(1)(ii)    ¨
Rule 15d-6    ¨

Approximate number of holders of record as of the certification or notice date: 1

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, ZymoGenetics, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date: October 22, 2010     By:   /s/ P. Joseph Campisi, Jr.
    Name:     P. Joseph Campisi, Jr.
    Title:   Vice President

 

2

-----END PRIVACY-ENHANCED MESSAGE-----